| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pharmacology, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612
Much evidence indicates that cAMP-dependent protein kinase (PKA) prevents increased endothelial permeability induced by inflammatory mediators. We investigated the hypothesis that PKA inhibits Rho GTPases, which are regulator proteins believed to mediate endothelial barrier dysfunction. Stimulation of human microvascular endothelial cells (HMEC) with thrombin (10 nM) increased activated RhoA (RhoA-GTP) within 1 min, which remained elevated approximately fourfold over control for 15 min. The activation was accompanied by RhoA translocation to the cell membrane. However, thrombin did not activate Cdc42 or Rac1 within similar time points, indicating selectivity of activation responses by Rho GTPases. Pretreatment of HMEC with 10 µM forskolin plus 1 µM IBMX (FI) to elevate intracellular cAMP levels inhibited both thrombin-induced RhoA activation and translocation responses. FI additionally inhibited thrombin-mediated dissociation of RhoA from guanine nucleotide dissociation inhibitor (GDI) and enhanced in vivo incorporation of 32P by GDI. HMEC pretreated in parallel with FI showed >50% reduction in time for the thrombin-mediated resistance drop to return to near baseline and inhibition of ~23% of the extent of resistance drop. Infection of HMEC with replication-deficient adenovirus containing the protein kinase A inhibitor gene (PKA inhibitor) blocked both the FI-mediated protective effects on RhoA activation and resistance changes. In conclusion, the results provide evidence that PKA inhibited RhoA activation in endothelial cells, supporting a signaling mechanism of protection against vascular endothelial barrier dysfunction.
Rho guanosine 5'-triphosphate; protein kinase A inhibitor; guanine nucleotide dissociation inhibitor; endothelial resistance
This article has been cited by other articles:
|
|
 |
|
  J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Moore, J. P. Correia, K. Lai Wing Sun, M. Pool, A. E. Fournier, and T. E. Kennedy Rho inhibition recruits DCC to the neuronal plasma membrane and enhances axon chemoattraction to netrin 1 Development, September 1, 2008; 135(17): 2855 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mahadev, X. Wu, S. Donnelly, R. Ouedraogo, A. D. Eckhart, and B. J. Goldstein Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells Cardiovasc Res, May 1, 2008; 78(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Adamson, J. C. Ly, R. K. Sarai, J. F. Lenz, A. Altangerel, D. Drenckhahn, and F. E. Curry Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1188 - H1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lorenowicz, M. Fernandez-Borja, and P. L. Hordijk cAMP Signaling in Leukocyte Transendothelial Migration Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1014 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Birukova, P. Fu, S. Chatchavalvanich, D. Burdette, O. Oskolkova, V. N. Bochkov, and K. G. Birukov Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L924 - L935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Su, M. Hodnett, N. Wu, A. Atakilit, C. Kosinski, M. Godzich, X. Z. Huang, J. K. Kim, J. A. Frank, M. A. Matthay, et al. Integrin {alpha}vbeta5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 377 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Fessler, P. G. Arndt, I. Just, J. A. Nick, K. C. Malcolm, and G. Scott Worthen Dual role for RhoA in suppression and induction of cytokines in the human neutrophil Blood, February 1, 2007; 109(3): 1248 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Kim, J.-G. Kim, M.-Y. Moon, C.-Y. Jeon, H.-Y. Won, H.-J. Kim, Y.-J. Jeon, J.-Y. Seo, J.-I. Kim, J. Kim, et al. Transforming growth factor-beta1 regulates macrophage migration via RhoA Blood, September 15, 2006; 108(6): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Qiao, F. Huang, R. P. Naikawadi, K. S. Kim, T. Said, and H. Lum Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4 Am J Physiol Lung Cell Mol Physiol, July 1, 2006; 291(1): L91 - L101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Niwano, M. Arai, N. Koitabashi, S. Hara, A. Watanabe, K. Sekiguchi, T. Tanaka, T. Iso, and M. Kurabayashi Competitive Binding of CREB and ATF2 to cAMP/ATF Responsive Element Regulates eNOS Gene Expression in Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Fischmeister Is cAMP Good or Bad?: Depends on Where It's Made Circ. Res., March 17, 2006; 98(5): 582 - 584. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Huang, P. V. Subbaiah, O. Holian, J. Zhang, A. Johnson, N. Gertzberg, and H. Lum Lysophosphatidylcholine increases endothelial permeability: role of PKC{alpha} and RhoA cross talk Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L176 - L185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-Y. Zhang, Y. Shirasawa, X. Chen, H. Yu, and J. N. Benoit Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G603 - G608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waschke, F. E. Curry, R. H. Adamson, and D. Drenckhahn Regulation of actin dynamics is critical for endothelial barrier functions Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1296 - H1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cullere, S. K. Shaw, L. Andersson, J. Hirahashi, F. W. Luscinskas, and T. N. Mayadas Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase Blood, March 1, 2005; 105(5): 1950 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waschke, D. Drenckhahn, R. H. Adamson, H. Barth, and F. E. Curry cAMP protects endothelial barrier functions by preventing Rac-1 inhibition Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2427 - H2433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Birukova, F. Liu, J. G. N. Garcia, and A. D. Verin Protein kinase A attenuates endothelial cell barrier dysfunction induced by microtubule disassembly Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L86 - L93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kouklis, M. Konstantoulaki, S. Vogel, M. Broman, and A. B. Malik Cdc42 Regulates the Restoration of Endothelial Barrier Function Circ. Res., February 6, 2004; 94(2): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird Thrombin and Phenotypic Modulation of the Endothelium Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 41 - 53. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
